Table 1.

Clinicodemographic variables for patients with LGSC.

Prognostic factor	Subgroups	N	Percentage
BMI	17 to < 25	28	35
	25 to < 30	18	22
	30 to <35	19	23
	35 to < 40	6	7
	40 or more	3	4
	Not reported	7	9
History of HRT use	Yes	10	12
	No	59	73
	Not reported	12	15
Previous surgery on tubes/ovaries	Yes	12	85
	No	69	15
Previous hysterectomy	Yes	20	25
	No	61	75
History of OCP use	Yes	7	9
	No	65	80
	Not reported	9	11
Smoking history	Previous history or current	15	19
	Non-smoker	66	81
Debulking	Optimal	65	80
	Sub-optimal	7	9
	Not reported	9	11
Stage	I	20	25
	II	6	7
	III	48	59
	IV	5	6
	Not reported	2	2
Race	White	59	73
	Black	15	19
	Asian	1	1
	Hispanic	2	2
	Unknown	4	5
Parity	0	19	23
	1	11	14
	2	24	30
	3	11	14
	4	5	6
	>5	3	3
	Not reported	8	10
Medical history	CHF	2	2
	Previous MI	3	4
	CAD	1	1
	Previous stroke	2	2
	Hypertension	23	28
	Diabetes mellitus	5	6
	Deep vein thrombosis	5	6
Family history of ovarian cancer	Yes	28	35
	No	53	65
Disease status	No evidence of disease	26	32
	Alive with disease	11	14
	Dead of disease	20	25
	Dead of intercurrent causes	2	2
	Unknown	10	12
	Lost to follow-up	12	15